Perrigo (PRGO) Return on Capital Employed (2013 - 2026)
Perrigo (PRGO) posted quarterly Return on Capital Employed of 21.23% for Q1 2026, down 2372.0% year-over-year from 0.93% in Q1 2025, and down 56.93% quarter-over-quarter from 13.53% in Q4 2025.
Perrigo (PRGO) Return on Capital Employed (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Return on Capital Employed for 14 consecutive years, with 21.23% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 2372.0% year-over-year to 21.23%; the TTM figure through Mar 2026 stood at 21.23% (down 2372.0% YoY), while the FY2025 annual figure was 13.89%, down 1512.0% from the prior year.
- Return on Capital Employed declined to 21.23% in Q1 2026 per PRGO's latest filing, from 13.53% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 5.18% in Q3 2022 and bottomed at 21.23% in Q1 2026.
- Historically, Return on Capital Employed has averaged 0.43% across 5 years, with a median of 1.2% in 2024.
- Annual changes were most pronounced in 2022 — Return on Capital Employed surged 474 bps — and 2026, when it sank 2372 bps.
- Perrigo's Return on Capital Employed stood at 0.81% in 2022, then soared by 104 bps to 1.65% in 2023, then retreated by 27 bps to 1.2% in 2024, then slumped by 1224 bps to 13.53% in 2025, then tumbled by 57 bps to 21.23% in 2026.
- Business Quant data shows PRGO's Return on Capital Employed at 21.23% in Q1 2026, 13.53% in Q4 2025, and 3.12% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Perrigo | 1.92 Bn | 1.52 Bn | 313.90 Mn | -23.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -23.19% |
| Mar 28, 2026 | -21.23% |
| Dec 31, 2025 | -13.53% |
| Sep 27, 2025 | 3.12% |
| Jun 28, 2025 | 3.26% |
| Mar 29, 2025 | 2.49% |
| Dec 31, 2024 | 1.20% |
| Sep 28, 2024 | -0.18% |
| Jun 29, 2024 | -0.39% |
| Mar 30, 2024 | 0.52% |
| Dec 31, 2023 | 1.65% |
| Sep 30, 2023 | 2.01% |
| Jul 1, 2023 | 1.71% |
| Apr 1, 2023 | 1.07% |
| Dec 31, 2022 | 0.81% |
| Oct 1, 2022 | 0.97% |
| Jul 2, 2022 | 5.18% |
| Apr 2, 2022 | 4.04% |
| Dec 31, 2021 | 4.52% |
| Oct 2, 2021 | 4.43% |